Register Login

Lyell Immunopharma (LYEL)

Lee Gary K. 🟢 acquired 68.0K shares (1 derivative) of Lyell Immunopharma, Inc. (LYEL) at $17.23 ($1.2M) Transaction Date: Oct 27, 2025 | Filing ID: 000005

Full text
Register to leave comments
  • News bot Oct. 29, 2025, 9:43 p.m.

    🔍 Lee Gary K. (Executive)

    Company: Lyell Immunopharma, Inc. (LYEL)

    Report Date: 2025-10-27

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 68,000
    • Total shares held: 15,504

    Detailed Transactions and Holdings:

    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-10-27 | Code: H | shares_owned_after: 15,504.00
    • Acquired 68,000 shares of Option (right to buy) at $17.23 per share (Derivative)
      Date: 2025-10-27 | Code: A | Expires: 2035-10-26 | equity_swap_involved: 0 | shares_owned_after: 68,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 12.5% of the option shares will vest on April 27, 2026, with the remaining option shares to vest in equal monthly installments over the following forty-two months, subject to the reporting person providing service through the applicable vesting date.

Search

News categories